36 related articles for article (PubMed ID: 38602626)
1. Single-cell transcriptomic analysis identifies infiltrating plasmacytoid dendritic cells in psoriasis epidermis.
Luo L; Cheng H; Liu Z; Olszewski P; Pasquali L; Xu N; Enge M; Pivarcsi A; Sonkoly E
Br J Dermatol; 2024 May; ():. PubMed ID: 38776409
[No Abstract] [Full Text] [Related]
2. 3,3'-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice.
Rasool M; Srikanth M; Rithvik A
In Vitro Cell Dev Biol Anim; 2024 Apr; ():. PubMed ID: 38602626
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
6. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
7. Distinctive downmodulation of plasmacytoid dendritic cell functions by vitamin D3 analogue calcipotriol.
Suzuki T; Tatsuno K; Ito T; Sakabe JI; Funakoshi A; Tokura Y
J Dermatol Sci; 2016 Oct; 84(1):71-79. PubMed ID: 27342039
[TBL] [Abstract][Full Text] [Related]
8. Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
Kamata M; Tada Y
Front Immunol; 2022; 13():941071. PubMed ID: 35837394
[TBL] [Abstract][Full Text] [Related]
9. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
Srikanth M; Rasool M
Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
[TBL] [Abstract][Full Text] [Related]
10. Role of interferon regulatory factor-mediated signaling in psoriasis.
Wang WM; Li F; Jin HZ
Int J Med Sci; 2021; 18(16):3794-3799. PubMed ID: 34790055
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-Diindolylmethane alleviates acute atopic dermatitis by regulating T cell differentiation in a mouse model.
Wu X; Liu J; Chen C; Huang Z; Zang Y; Chen J; Dong L; Zhang J; Ding Z
Mol Immunol; 2021 Feb; 130():104-112. PubMed ID: 33309306
[TBL] [Abstract][Full Text] [Related]
12. Adaptive and Innate Immunity in Psoriasis and Other Inflammatory Disorders.
Schön MP
Front Immunol; 2019; 10():1764. PubMed ID: 31402919
[TBL] [Abstract][Full Text] [Related]
13. Regulating IRFs in IFN Driven Disease.
Jefferies CA
Front Immunol; 2019; 10():325. PubMed ID: 30984161
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
